AMPX Form 144: 65,654 shares from vested RSUs to be sold on NYSE
Rhea-AI Filing Summary
Amprius Technologies, Inc. (AMPX) submitted a Form 144 notice for a proposed sale of common stock through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $447,511. The filing lists 65,654 shares to be sold on 08/21/2025 on the NYSE. The securities were reported as acquired on 08/20/2025 upon the release of restricted stock units from the issuer and were indicated as compensation, with 126,191 shares shown as the amount acquired. The filing reports 125,075,837 shares outstanding. No sales by the reporting person were reported in the past three months. The filer attests there is no undisclosed material adverse information.
Positive
- Broker and market specified: Sale to be executed through Morgan Stanley Smith Barney LLC on the NYSE, providing clear execution channel.
- Acquisition clearly disclosed: Shares were acquired by release of restricted stock units and recorded as compensation.
Negative
- None.
Insights
TL;DR: Routine insider sale notice: newly vested RSUs being sold through a broker, no prior sales reported in the last three months.
The Form 144 documents a proposed sale of 65,654 common shares via Morgan Stanley Smith Barney with an aggregate market value of $447,511, to occur on 08/21/2025. The shares were acquired on 08/20/2025 through release of restricted stock units and are labeled as compensation. The filing discloses 125,075,837 shares outstanding and states there were no securities sold in the past three months by the reporting person. This is a standard Form 144 disclosure required for certain insider sales and contains no additional commentary or indications of undisclosed material events.
TL;DR: Compliance-focused filing showing issuance and planned sale of vested RSUs; conforms to Rule 144 requirements.
The notice identifies the broker, the class of securities, the number of shares to be sold, and the method of acquisition (release of restricted stock units) with payment characterized as compensation. The signer affirms lack of material non-public information. There are no disclosures of prior sales within the trailing three-month period. From a governance and disclosure perspective, the form contains the elements expected for an insider sale under Rule 144.